Macrocyclic indole derivatives useful as hepatitis C virus inhibitors
US8357687B2 · kind B2 · utility
1Cited by
4References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 14, 2009 |
| Grant date | Jan 22, 2013 |
| Priority date | — |
| Expiry date | Aug 14, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Inhibitors of HCV replication of formula (I) including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein Y, R1, R2, R4 and n have the meaning defined in the claims. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use in HCV therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.